North America region held the highest share in 2023.
Antisense and RNAi Therapeutics Market was valued at US$ 1.63 Bn. in 2023 and is expected to reach US$ 3.38 Bn. by 2030, at a CAGR of 11% du...
North America region held the highest share in 2023.
Antisense and RNAi Therapeutics Market was valued at US$ 1.63 Bn. in 2023 and is expected to reach US$ 3.38 Bn. by 2030, at a CAGR of 11% dur...